{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:06:32Z","timestamp":1776254792628,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160335"],"award-info":[{"award-number":["82160335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160335"],"award-info":[{"award-number":["82160335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02264-9","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:07:25Z","timestamp":1773036445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of CT-based radiomics models for the prediction of human epidermal growth factor receptor 2 status in gastric cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaolian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Situ","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zonghuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"3","key":"2264_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"2264_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17(7):395\u2013417. https:\/\/doi.org\/10.1038\/s41571-020-0341-y.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"2264_CR3","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1158\/1078-0432.CCR-18-2275","volume":"25","author":"F Meric-Bernstam","year":"2019","unstructured":"Meric-Bernstam F, et al. Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer. Clin Cancer Res. 2019;25(7):2033\u201341. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-2275.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2264_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-019-0268-3","volume":"17","author":"DY Oh","year":"2020","unstructured":"Oh DY, Bang YJ. HER2-targeted therapies - a role beyond breast cancer. Nat Rev Clin Oncol. 2020;17(1):33\u201348. https:\/\/doi.org\/10.1038\/s41571-019-0268-3.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9742","key":"2264_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(10)61121-X.","journal-title":"Lancet"},{"issue":"6","key":"2264_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S1470-2045(20)30169-8","volume":"21","author":"YY Janjigian","year":"2020","unstructured":"Janjigian YY, et al. First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial. Lancet Oncol. 2020;21(6):821\u201331. https:\/\/doi.org\/10.1016\/S1470-2045(20)30169-8.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2264_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-013-0252-z","volume":"17","author":"N Boku","year":"2014","unstructured":"Boku N. HER2-positive gastric cancer. Gastric Cancer. 2014;17(1):1\u201312. https:\/\/doi.org\/10.1007\/s10120-013-0252-z.","journal-title":"Gastric Cancer"},{"issue":"7","key":"2264_CR8","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2967\/jnumed.115.171165","volume":"57","author":"R Chen","year":"2016","unstructured":"Chen R, et al. Relationship Between 18F-FDG PET\/CT Findings and HER2 Expression in Gastric Cancer. J Nucl Med. 2016;57(7):1040\u20134. https:\/\/doi.org\/10.2967\/jnumed.115.171165.","journal-title":"J Nucl Med"},{"key":"2264_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1186\/s12885-015-1726-7","volume":"15","author":"J He","year":"2015","unstructured":"He J, et al. Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study. BMC Cancer. 2015;15:749. https:\/\/doi.org\/10.1186\/s12885-015-1726-7.","journal-title":"BMC Cancer"},{"issue":"5","key":"2264_CR10","doi-asserted-by":"publisher","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","volume":"27","author":"EC Smyth","year":"2016","unstructured":"Smyth EC, et al. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(5):v38\u201349. https:\/\/doi.org\/10.1093\/annonc\/mdw350.","journal-title":"Ann Oncol"},{"issue":"8","key":"2264_CR11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","volume":"18","author":"A Hosny","year":"2018","unstructured":"Hosny A, et al. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18(8):500\u201310. https:\/\/doi.org\/10.1038\/s41568-018-0016-5.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2264_CR12","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.1007\/s00330-022-08704-8","volume":"32","author":"Q Chen","year":"2022","unstructured":"Chen Q, et al. Radiomics in precision medicine for gastric cancer: opportunities and challenges. Eur Radiol. 2022;32(9):5852\u201368. https:\/\/doi.org\/10.1007\/s00330-022-08704-8.","journal-title":"Eur Radiol"},{"key":"2264_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.radonc.2020.06.004","volume":"150","author":"J Yang","year":"2020","unstructured":"Yang J, et al. Integrating tumor and nodal radiomics to predict lymph node metastasis in gastric cancer. Radiother Oncol. 2020;150:89\u201396. https:\/\/doi.org\/10.1016\/j.radonc.2020.06.004.","journal-title":"Radiother Oncol"},{"issue":"8","key":"2264_CR14","doi-asserted-by":"publisher","first-page":"e2121143","DOI":"10.1001\/jamanetworkopen.2021.21143","volume":"4","author":"W Wang","year":"2021","unstructured":"Wang W, et al. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer. JAMA Netw Open. 2021;4(8):e2121143. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.21143.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2264_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13244-022-01361-x","volume":"14","author":"H Zhao","year":"2023","unstructured":"Zhao H, et al. Development and external validation of a radiomics model for assessment of HER2 positivity in men and women presenting with gastric cancer. Insights Imaging. 2023;14(1):20. https:\/\/doi.org\/10.1186\/s13244-022-01361-x.","journal-title":"Insights Imaging"},{"issue":"3","key":"2264_CR16","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1016\/j.acra.2020.02.018","volume":"28","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. CT Radiomics for Distinction of Human Epidermal Growth Factor Receptor 2 Negative Gastric Cancer. Acad Radiol. 2021;28(3):e86\u201392. https:\/\/doi.org\/10.1016\/j.acra.2020.02.018.","journal-title":"Acad Radiol"},{"key":"2264_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2020.00053","volume":"10","author":"Q Sun","year":"2020","unstructured":"Sun Q, et al. Deep Learning vs. Radiomics for Predicting Axillary Lymph Node Metastasis of Breast Cancer Using Ultrasound Images: Don\u2019t Forget the Peritumoral Region. Front Oncol. 2020;10:53. https:\/\/doi.org\/10.3389\/fonc.2020.00053.","journal-title":"Front Oncol"},{"issue":"2","key":"2264_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani JA, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(2):167\u201392. https:\/\/doi.org\/10.6004\/jnccn.2022.0008.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"2264_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139. https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2264_CR20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41416-019-0399-4","volume":"120","author":"L Fornaro","year":"2019","unstructured":"Fornaro L, et al. Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer. Br J Cancer. 2019;120(5):522\u20136. https:\/\/doi.org\/10.1038\/s41416-019-0399-4.","journal-title":"Br J Cancer"},{"issue":"6","key":"2264_CR21","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2214\/AJR.20.23528","volume":"216","author":"H Zhao","year":"2021","unstructured":"Zhao H, et al. Dual-Energy CT-Based Nomogram for Decoding HER2 Status in Patients With Gastric Cancer. AJR Am J Roentgenol. 2021;216(6):1539\u201348. https:\/\/doi.org\/10.2214\/AJR.20.23528.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2264_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.21147\/j.issn.1000-9604.2020.01.08","volume":"32","author":"Y Li","year":"2020","unstructured":"Li Y, et al. A CT-based radiomics nomogram for prediction of human epidermal growth factor receptor 2 status in patients with gastric cancer. Chin J Cancer Res. 2020;32(1):62\u201371. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2020.01.08.","journal-title":"Chin J Cancer Res"},{"issue":"3","key":"2264_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000368555","volume":"88","author":"JS Park","year":"2015","unstructured":"Park JS, et al. Clinicopathological features and prognostic significance of HER2 expression in gastric cancer. Oncology. 2015;88(3):147\u201356. https:\/\/doi.org\/10.1159\/000368555.","journal-title":"Oncology"},{"issue":"12","key":"2264_CR24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749\u201362. https:\/\/doi.org\/10.1038\/nrclinonc.2017.141.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"2264_CR25","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1148\/radiol.2021203281","volume":"301","author":"Q Sun","year":"2021","unstructured":"Sun Q, et al. Biologic Pathways Underlying Prognostic Radiomics Phenotypes from Paired MRI and RNA Sequencing in Glioblastoma. Radiology. 2021;301(3):654\u201363. https:\/\/doi.org\/10.1148\/radiol.2021203281.","journal-title":"Radiology"},{"issue":"12","key":"2264_CR26","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.1002\/cam4.1863","volume":"7","author":"ZC Li","year":"2018","unstructured":"Li ZC, et al. Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma. Cancer Med. 2018;7(12):5999\u20136009. https:\/\/doi.org\/10.1002\/cam4.1863.","journal-title":"Cancer Med"},{"issue":"2","key":"2264_CR27","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1148\/radiol.2017161375","volume":"284","author":"S Gourtsoyianni","year":"2017","unstructured":"Gourtsoyianni S, et al. Primary Rectal Cancer: Repeatability of Global and Local-Regional MR Imaging Texture Features. Radiology. 2017;284(2):552\u201361. https:\/\/doi.org\/10.1148\/radiol.2017161375.","journal-title":"Radiology"},{"issue":"6","key":"2264_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13244-012-0196-6","volume":"3","author":"F Davnall","year":"2012","unstructured":"Davnall F, et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging. 2012;3(6):573\u201389. https:\/\/doi.org\/10.1007\/s13244-012-0196-6.","journal-title":"Insights Imaging"},{"key":"2264_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jclinepi.2015.04.005","volume":"69","author":"EW Steyerberg","year":"2016","unstructured":"Steyerberg EW, et al. Prediction models need appropriate internal, internal-external, and external validation. J Clin Epidemiol. 2016;69:245\u20137. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.04.005.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2264_CR30","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ajodo.2023.08.003","volume":"164","author":"D Valkenborg","year":"2023","unstructured":"Valkenborg D, et al. Support vector machines. Am J Orthod Dentofac Orthop. 2023;164(5):754\u20137. https:\/\/doi.org\/10.1016\/j.ajodo.2023.08.003.","journal-title":"Am J Orthod Dentofac Orthop"},{"issue":"1","key":"2264_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12916-019-1426-2","volume":"17","author":"CJ Kelly","year":"2019","unstructured":"Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019;17(1):195. https:\/\/doi.org\/10.1186\/s12916-019-1426-2.","journal-title":"BMC Med"},{"issue":"11","key":"2264_CR32","doi-asserted-by":"publisher","first-page":"e0224365","DOI":"10.1371\/journal.pone.0224365","volume":"14","author":"A Vabalas","year":"2019","unstructured":"Vabalas A, et al. Machine learning algorithm validation with a limited sample size. PLoS ONE. 2019;14(11):e0224365. https:\/\/doi.org\/10.1371\/journal.pone.0224365.","journal-title":"PLoS ONE"},{"key":"2264_CR33","doi-asserted-by":"publisher","unstructured":"Erickson BJ, et al. Machine learning for medical imaging. Radiographics. 2017 Mar-Apr;37(2):505\u201315. https:\/\/doi.org\/10.1148\/rg.2017160130.","DOI":"10.1148\/rg.2017160130"},{"issue":"1","key":"2264_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12859-018-2451-4","volume":"19","author":"H Sanz","year":"2018","unstructured":"Sanz H, et al. SVM-RFE: selection and visualization of the most relevant features through non-linear kernels. BMC Bioinformatics. 2018;19(1):432. https:\/\/doi.org\/10.1186\/s12859-018-2451-4.","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"2264_CR35","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/bioinformatics\/btq037","volume":"26","author":"B Hanczar","year":"2010","unstructured":"Hanczar B, et al. Small-sample precision of ROC-related estimates. Bioinformatics. 2010;26(6):822\u201330. https:\/\/doi.org\/10.1093\/bioinformatics\/btq037.","journal-title":"Bioinformatics"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02264-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02264-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02264-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:20:43Z","timestamp":1776252043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02264-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2264"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02264-9","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Institutional Review Board and Ethical Committee of The Jiangxi Provincial People\u2019s Hospital (Approval No.: SKJP1320242340). The need for informed consent was waived by the ethics committee of The Jiangxi Provincial People\u2019s Hospital, because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was reported in accordance with the TRIPOD (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis) statement.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Reporting guidelines"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}